World Aids Day December 1st 2018
AVAC’s Resource Database- Now available on Mesh's New 'Other Networks' page

The AIDS Vaccine Advocacy Coalition, now AVAC, aims to speed the development of preventive HIV vaccines. Their work cuts across different prevention approaches and includes a range of activities including, addressing ethical issues, community involvement in research and promoting community engagement and research literacy outside the context of a specific clinical trial or intervention. Their resource database contains a wide range of materials covering the spectrum of issues and interventions related to biomedical HIV prevention research and implementation. Many  AVAC publications translate the complex issues of biomedical HIV prevention research to help policymakers, advocates and program managers make informed decisions. Resources include the Communications Handbook for Clinical Trials and AVAC Report 2017: Mixed messages and how to untangle them which explores many of the mixed communications, rhetoric and assumptions around HIV/Aids programming. All are available digitally here and physical copies of select items are available to order here.

New Other Networks Page on Mesh

Mesh aims to bring together those working in Community Engagement with health research across Low and Middle Income Countries. Part of this role involves connecting readers with other networks and knowledge platforms that may help you to find collaborators and resources in your field or perhaps inspiration from work in adjacent fields such as international development. To help with this we have created a new ‘Other Networks’ page.

The page depicts some of Mesh’s closest partner organisations as well as listing and linking you to some other organisations and networks, which may be of interest.
If you would like to suggest a network to add to this list please get in  

Vaccine Hesitant Communities: Call to Mesh users to share materials and advice

One of our Mesh users has set up a discussion on Mesh with the aim of sharing experiences, literature and resources around working in communities where there is vaccine hesitancy. If you have something to share, are doing similar work or have questions around the issue join the group, start a topic and add your ideas and materials to the conversation.

There is also a blog post on the issue on our sister site eMOPs.

News from the Field

Call for Researchers and Journalists interested in reporting Neglected Tropical Diseases (NTDs)

In Low and Middle Income Countries, media can play a critical role in linking research evidence to the public. Journalists who’ve been trained to interpret and communicate research findings can help fuel behaviour change and improved health, which translates into progressive national development.

In December 2017, the 'Uniting to Combat Neglected Tropical Diseases Coalition' will release the 5th Progress Report of the London Declaration to End Neglected Tropical Diseases (NTDs). The goal is to increase support for investments in NTD control programmes, thus helping the more than 1.5 billion people worldwide who suffer from these diseases, and to prevent millions more from contracting them.

UCNTD wants to help more journalists explore the issues related to NTD control and prevention. If you are a journalist or a researcher working in an LMIC, and you know a local journalist who covers health issues, UCNTD would like to work with them to produce stories about the 5th Progress Report release and about NTD issues going forward.

If you’d like to help, please contact Rachel Jones, UCNTD Media Consultant, at

Good Participatory Practices Mapping Project (GPP MAP)

FHI360, a nonprofit human development organisation, is conducting a Good Participatory Practices Mapping Project – the GPP MAP. They Are looking for organisations who have been involved in clinical research around HIV, Tuberculosis, Ebola, or Zika to contribute to the development of a framework to support the evaluation Good Participatory Practices (GPP) in clinical trials. FHI360 plan to create a conceptual map to depict the  ways Good Participatory Practice is considered across different  biomedical trials.
To find out more and to participate, by completing their online survey please visit here